Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies. [electronic resource]
- British journal of haematology Jun 2009
- 569-80 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
1365-2141
10.1111/j.1365-2141.2009.07657.x doi
Antineoplastic Agents--therapeutic use Autoimmune Diseases--drug therapy Hematologic Neoplasms--drug therapy Humans Leukemia--drug therapy Lymphoproliferative Disorders--drug therapy Protein Kinase Inhibitors--therapeutic use Protein Kinases--metabolism Signal Transduction--drug effects Sirolimus--therapeutic use TOR Serine-Threonine Kinases